-
MD Anderson to launch cancer survivorship training for PCPs
There are more than 18 million cancer survivors living in the U.S., but few primary care providers know how to care for this patient group. To close the gap, Houston-based the University of Texas MD Anderson Cancer Center is launching a survivorship training program for primary care providers. -
Sylvester surgeon 1st to use blue laser to treat laryngeal cancer
A surgeon at Miami-based Sylvester Comprehensive Cancer Center is the first in the U.S. to use a blue laser to treat early glottic cancer, a common type of laryngeal cancer. -
Providence launches 1st-of-its-kind cancer study
Renton, Wash.-based Providence is launching a first-of-its-kind study to examine the real-world implementation of multi-cancer early-detection blood tests. -
Ultrasounds ineffective in detecting this cancer in Black women: Study
Transvaginal ultrasounds fail to detect endometrial cancer in up to 11.4% of Black women, according to research from a Seattle-based University of Washington study published June 27 in JAMA Oncology. -
MD Anderson, Rice partner to advance bioengineering research
The University of MD Anderson Cancer Center and Rice University, both based in Houston, have launched a Cancer Bioengineering Collaborative, a hub that aims to advance cancer research and accelerate the time it takes to turn findings into clinical use. -
Duke Health's hackathon-style cancer program for high schoolers
Hackathons — events wherein programmers come together for days at a time to solve a problem — are a staple in the technology community. Durham, N.C.-based Duke Health is using a similar model to get high school students excited about the medical field. -
Penn State Health breaks ground on cancer center
Hersey, Pa.-based Penn State Health broke ground on its new cancer center. -
Not all cancer needs to be cured: AAMC
In an age of advanced technology and personalized medicine, curing prostate cancer is not always necessary, the Association of American Medical Colleges said in a June 25 article. -
Stanford physicist who developed cancer treatments dies at 51
Wu Liu, PhD, a medical physicist who created new imaging techniques and radiation treatments for cancer, died May 14 of brain cancer at 51. -
6 guidelines from ASCO on AI, cancer care
Leaders at the American Society of Clinical Oncology published a formal document June 25 that outlines what the group deems as the most appropriate use of artificial intelligence when it comes to clinical oncology care. -
Cancer cases rising, but deaths falling: 10 things to know
There are predicted to be approximately 1.96 million new cancer cases in 2023, with a projected 609,000 deaths, USA Facts reported. -
Connecticut hospital seeks to move oncology services
The Hospital of Central Connecticut, part of Hartford (Conn.) Healthcare, has filed an application with the state seeking permission to relocate its medical oncology service in a move it said will better accommodate expansions, the Hartford Business Journal reported June 21. -
AdventHealth launches 1st-of-kind cancer vaccine trial
Orlando, Fla.-based AdventHealth Cancer Institute launched a first-of-its-kind bladder cancer vaccine trial that will use patient-customized mRNA vaccines. -
UNC's cancer center taps executive director
Chapel Hill, N.C.-based Lineberger Comprehensive Cancer Center, part of the University of North Carolina, has tapped Robert Ferris, MD, PhD, to become its next executive director, it announced June 19. -
Former Ohio oncology chief passes
Nathan Berger, MD, University Hospitals Seidman Cancer Center's former chief of the hematology and oncology division, died June 16. -
Creating 'hometown flavor' in cancer care
Like many small hospitals, Doylestown (Pa.) Health provides cancer care but often sees patients going to larger centers such as Fox Chase Cancer Center or Penn Medicine, both based in Philadelphia. This has led Sean Reinhardt, MD, chief medical officer at Doylestown, to ask, "How can we create a cancer care environment that people want to stay in?" -
Pfizer to have 8 'blockbuster' cancer drugs by 2030
Pfizer anticipates developing eight or more potential "blockbuster" cancer drugs by 2030. -
States with the highest, lowest incidence rates of cancer
Kentucky has the highest cancer incidence rate, while Nevada has the lowest, a USAFacts report found. -
Gen X may have higher cancer incidences than previous generations
A National Cancer Institute study found that members of Generation X may be experiencing larger per-capita increases in the incidence of cancer compared to any prior generation. -
Fox Chase gets additional $10.8M for pancreatic cancer research
Fox Chase Cancer Center in Philadelphia has been given $10.8 million to further pancreatic cancer research, it announced June 12.
Page 3 of 50